Ovid Therapeutics
OVID
OVID
60 hedge funds and large institutions have $99.8M invested in Ovid Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 60 → 60 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Holders
60
Holding in Top 10
1
Calls
$28K
Puts
$4K
Top Buyers
| 1 | +$990K | |
| 2 | +$446K | |
| 3 | +$391K | |
| 4 |
Millennium Management
New York
|
+$338K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$276K |
Top Sellers
| 1 | -$502K | |
| 2 | -$446K | |
| 3 | -$431K | |
| 4 |
TA
TLS Advisors
Miami,
Florida
|
-$281K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$264K |